BXC vs. AGX, BZH, LOMA, TPC, HOV, NX, GLDD, VSEC, LMB, and NOA
Should you be buying BlueLinx stock or one of its competitors? The main competitors of BlueLinx include Argan (AGX), Beazer Homes USA (BZH), Loma Negra Compañía Industrial Argentina Sociedad Anónima (LOMA), Tutor Perini (TPC), Hovnanian Enterprises (HOV), Quanex Building Products (NX), Great Lakes Dredge & Dock (GLDD), VSE (VSEC), Limbach (LMB), and North American Construction Group (NOA). These companies are all part of the "construction" sector.
BlueLinx (NYSE:BXC) and Argan (NYSE:AGX) are both small-cap construction companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability, community ranking and media sentiment.
90.8% of BlueLinx shares are owned by institutional investors. Comparatively, 79.4% of Argan shares are owned by institutional investors. 3.4% of BlueLinx shares are owned by insiders. Comparatively, 11.9% of Argan shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Argan received 120 more outperform votes than BlueLinx when rated by MarketBeat users. Likewise, 69.32% of users gave Argan an outperform vote while only 56.07% of users gave BlueLinx an outperform vote.
In the previous week, BlueLinx and BlueLinx both had 2 articles in the media. BlueLinx's average media sentiment score of 1.86 beat Argan's score of 0.67 indicating that BlueLinx is being referred to more favorably in the media.
BlueLinx presently has a consensus target price of $130.00, indicating a potential upside of 27.51%. Argan has a consensus target price of $70.00, indicating a potential upside of 2.40%. Given BlueLinx's higher probable upside, equities analysts clearly believe BlueLinx is more favorable than Argan.
BlueLinx has a beta of 1.96, meaning that its stock price is 96% more volatile than the S&P 500. Comparatively, Argan has a beta of 0.43, meaning that its stock price is 57% less volatile than the S&P 500.
Argan has a net margin of 5.64% compared to BlueLinx's net margin of 1.57%. BlueLinx's return on equity of 14.11% beat Argan's return on equity.
BlueLinx has higher revenue and earnings than Argan. BlueLinx is trading at a lower price-to-earnings ratio than Argan, indicating that it is currently the more affordable of the two stocks.
Summary
BlueLinx beats Argan on 9 of the 16 factors compared between the two stocks.
Get BlueLinx News Delivered to You Automatically
Sign up to receive the latest news and ratings for BXC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding BXC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
BlueLinx Competitors List
Related Companies and Tools